American Regent’s Vasopressin Questioned As Eagle Prepares ANDA Launch
Daiichi Sankyo Affiliate Holds 505(b)(2) NDA Approval For Vasostrict Rival
Eagle is launching its product at risk with an appeal pending • Source: Olivier Le Moal / Alamy Stock Photo